Publication Name	World Journal of Clinical Urology
Manuscript ID	26780
Country	United Kingdom

Received	2016-04-26 08:42
Peer-Review Started	2016-04-27 16:21
To Make the First Decision	2016-06-12 09:16
Return for Revision	2016-06-16 11:03
Revised	2016-06-27 17:07
Second Decision	2016-07-05 17:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-07-13 13:41
Articles in Press	2016-07-13 13:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-07-22 15:31
Publish the Manuscript Online	2016-07-24 22:27

ISSN	2219-2816 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Minireviews
Article Title	Does the molecular classification of breast cancer point the way for biomarker identification in prostate cancer?
Manuscript Source	Invited Manuscript
All Author List	William JF Green, Graham Ball and Des Powe
Funding Agency and Grant Number
Corresponding Author	Dr. Des Powe, PhD, Department of Cellular Pathology, Queen’s Medical Centre, Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7 2UH, United Kingom. des.powe@nottingham.ac.uk
Key Words	Prostate cancer; Molecular classification; Biomarker; Breast cancer; Prognostic
Core Tip	This paper demonstrates that prostate cancer (CaP) has defined molecular subtypes in a similar manner to breast cancer. The molecular classification and subsequent personalised treatment of breast cancer has revolutionised its management. It is becoming increa-singly apparent that the same principles may be applied to CaP, allowing more individualised treatment and informing clinical decision making.
Publish Date	2016-07-24 22:27
Citation	Green WJF, Ball G, Powe D. Does the molecular classification of breast cancer point the way for biomarker identification in prostate cancer? World J Clin Urol 2016; 5(2): 80-89
URL	http://www.wjgnet.com/2219-2816/full/v5/i2/80.htm
DOI	http://dx.doi.org/10.5410/wjcu.v5.i2.80

Full Article (PDF)	WJCU-5-80.pdf
Full Article (Word)	WJCU-5-80.doc
Manuscript File	26780-Review.doc
Answering Reviewers	26780-Answering reviewers.pdf
Audio Core Tip	26780-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	26780-Conflict-of-interest statement.pdf
Copyright License Agreement	26780-Copyright assignment.pdf
Peer-review Report	26780-Peer-review(s).pdf
Scientific Misconduct Check	26780-Scientific misconduct check.pdf
Scientific Editor Work List	26780-Scientific editor work list.pdf